ARTICLE | Distillery Techniques
Drug platforms
May 8, 2017 7:10 PM UTC
An in vitro differentiation protocol could generate V2a interneurons from HPSCs for use as cell therapies to treat SCI. The protocol had three steps: treating HPSCs with two tool compounds that inhibi...
BCIQ Company Profiles
BCIQ Target Profiles